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Article
FAM83D directs protein kinase CK1a to the mitotic
spindle for proper spindle positioning
Luke J Fulcher1, Zhengcheng He2 , Lin Mei2, Thomas J Macartney1, Nicola T Wood1, Alan R Prescott3,
Arlene J Whigham4, Joby Varghese1, Robert Gourlay1, Graeme Ball3, Rosemary Clarke4,
David G Campbell1, Christopher A Maxwell2 & Gopal P Sapkota1,*
Abstract
The concerted action of many protein kinases helps orchestrate
the error-free progression through mitosis of mammalian cells.
The roles and regulation of some prominent mitotic kinases, such
as cyclin-dependent kinases, are well established. However, these
and other known mitotic kinases alone cannot account for the
extent of protein phosphorylation that has been reported during
mammalian mitosis. Here we demonstrate that CK1a, of the casein
kinase 1 family of protein kinases, localises to the spindle and is
required for proper spindle positioning and timely cell division. CK1a
is recruited to the spindle by FAM83D, and cells devoid of FAM83D,
or those harbouring CK1a-binding-deficient FAM83DF283A/F283A knockin
mutations, display pronounced spindle positioning defects, and a
prolonged mitosis. Restoring FAM83D at the endogenous locus in
FAM83D/ cells, or artificially delivering CK1a to the spindle in
FAM83DF283A/F283A cells, rescues these defects. These findings implicate
CK1a as new mitotic kinase that orchestrates the kinetics and
orientation of cell division.
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Introduction
The prominent mitotic roles for kinases such as cyclin-dependent
kinases (CDKs), Aurora kinases, Polo-like kinases (PLKs) and Nima-
related kinases (NEKs) have been well characterised [1–7].
However, the role of Casein Kinase 1 alpha (CK1a) in mitosis, if
any, remains poorly defined. CK1a belongs to the CK1 family of
Ser/Thr protein kinases that are implicated in diverse roles in a
whole plethora of cellular processes, from Wnt signalling to the regu-
lation of circadian rhythms [8]. CK1 isoforms can phosphorylate
hundreds of proteins in vitro, with a preference for Ser/Thr residues
that conform to either a D/E-X-X-S*/T* or pS/pT-X-X-S*/T* motif
[9]. A recent mitotic phosphoproteomic study found that around half
of the identified phosphorylation sites conformed to the predicted
CK1-consensus phosphorylation motifs [10], potentially implying a
significant role for CK1 catalytic activity in mitotic protein phospho-
rylation. Yet, there is a lack of definitive evidence regarding whether
and how any of the CK1 isoforms, or CK1a in particular, are
involved in mitosis.
Regarded as constitutively active protein kinases, the regulation
of CK1 isoforms is critically important, yet poorly understood, espe-
cially when considering their participation in multiple, diverse,
cellular functions in many, different cellular compartments [8,11].
We recently reported that the FAM83 family of poorly characterised
proteins act as subcellular anchors for CK1 isoforms through the
conserved N-terminal domain of unknown function 1669
(DUF1669) [12]. Our findings that FAM83 proteins interact and co-
localise with different CK1 isoforms offer the tantalising possibility
that FAM83 proteins direct CK1 isoforms to specific subcellular
compartments, and in doing so, regulate their substrate availability/
accessibility [13]. In line with this, we have shown that FAM83G
[(aka protein associated with SMAD1 (PAWS1)] activates Wnt
signalling through its association with CK1a [14]. Here, we sought
to investigate the FAM83D protein, and define its physiological role
in relation to CK1 isoforms. Although FAM83D (aka spindle protein
CHICA) is poorly characterised, it has been shown to be recruited to
the mitotic spindle through its association with the microtubule-
associated protein hyaluronan-mediated motility receptor (HMMR,
aka RHAMM or CD168) [15–17]. Unlike the other FAM83 members
that appear to associate robustly with CK1a, we found that over-
expressed green fluorescent protein (GFP)-tagged FAM83D in asyn-
chronous cell extracts interacted rather weakly, yet selectively, with
CK1a [12], suggesting this could be a regulated interaction. Consis-
tent with this, in the course of an unbiased proteomic approach to
identify interactors of endogenous FAM83D from both asyn-
chronous and mitotic extracts, we discovered in this study that
FAM83D interacts with CK1a only in mitosis. As the kinetics of
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chromosomal alignment are delayed and the cell division axis is
altered following the depletion of FAM83D by siRNA, as well as in
cells lacking HMMR or those derived from HMMR knockout mice
[15–17], we hypothesised that these phenotypes could be potentially
explained by the non-delivery of CK1a to the spindle in the absence
of FAM83D or HMMR. Here, we show that the FAM83D–CK1a inter-
action is critically important for correct and efficient spindle posi-
tioning, as well as smooth progression through the cell division
cycle.
Results
FAM83D and CK1a interact only in mitosis
In order to investigate the role of FAM83D at physiological levels,
we first generated a FAM83D knockout U2OS cell line (FAM83D/)
(Fig EV1), along with a U2OS cell line harbouring an in-frame
homozygous knockin of a GFP tag at the C-terminus of the endoge-
nous FAM83D gene (FAM83DGFP/GFP) (Fig EV1), with CRISPR/Cas9
gene editing technology, and verified these by Western blotting
(Fig 1A) and DNA sequencing. Given the links between FAM83D
and mitosis [16,17], we next undertook an unbiased proteomic
approach to identify interactors of endogenous FAM83D-GFP from
either asynchronous or mitotic FAM83DGFP/GFP knockin cell extracts.
Mitotic cells were collected by shake-off, following either prometa-
phase arrest with nocodazole and a brief release into fresh medium
to allow them to progress into mitosis, or mitotic arrest with the Eg5
chromokinesin inhibitor S-trityl L-cysteine (STLC), which results in
monopolar spindle formation [18]. Mass spectrometric analysis of
anti-GFP immunoprecipitates (IPs) from both asynchronous and
mitotic cell extracts identified several known FAM83D interactors,
including HMMR, dynein light chain 1 (DYNLL1) and the transcrip-
tion factor BTB domain and CNC homolog 1 (BACH1) [12,16,19]
(Fig 1B), potentially revealing the constitutive FAM83D interactors.
Excitingly, the only interactor of FAM83D that was robustly identi-
fied from mitotic, but not asynchronous extracts, was CK1a
(Fig 1B). The mitotic interactions observed between FAM83D and
CK1a or BACH1 constitute novel findings (Fig 1C).
We sought to validate the interaction between FAM83D and
CK1a at the endogenous level. Endogenous CK1a was detected in
anti-GFP IPs from nocodazole-synchronised mitotic but not asyn-
chronous FAM83DGFP/GFP cell extracts (Fig 1D). CK1d and e did not
interact with FAM83D, but the known FAM83D interactors HMMR
and DYNLL1 were detected in FAM83D IPs from both asynchronous
and mitotic cell extracts, suggesting a constitutive mode of interac-
tion (Fig 1D). A striking electrophoretic mobility shift of FAM83D
was observed in mitosis compared to asynchronous cells, suggesting
a potential post-translational modification (PTM) (Fig 1D). In
mitotic extracts collected from FAM83DGFP/GFP cells following
synchronisation with STLC, endogenous CK1a was also detected in
anti-GFP IPs (Fig 1E). Moreover, in cells that were exposed to either
nocodazole or STLC but were non-mitotic (i.e. adherent cells that
did not shake-off following drug treatment), no interaction between
CK1a and FAM83D was observed (Fig 1E), ruling out possible drug-
dependent stimulation of the CK1a–FAM83D interaction. To rule
out the possibility that the GFP tag on FAM83D might influence its
interaction with CK1a, we employed the 2G PAI1 U2OS cell line,
which harbours a non-fused GFP tag on the PAI1 locus [20], as a
control. Indeed, anti-GFP IPs from these cells did not co-precipitate
CK1a (Fig 1E). Cell cycle stages in asynchronous and mitotic cells
were confirmed by flow cytometry following propidium iodide stain-
ing (Fig 1F). At the endogenous level in wild-type U2OS cells, CK1a
was detected in anti-FAM83D IPs only from mitotic but not asyn-
chronous extracts, while FAM83D was identified in both. Neither
FAM83D nor CK1a were detected in control IgG IPs (Fig 1G). The
mitotic electrophoretic mobility shift of endogenous FAM83D was
also apparent in wild-type U2OS cells (Fig 1G). Endogenous
FAM83D was detected in anti-CK1a IPs only from mitotic but not
asynchronous extracts, while CK1a was identified in both (Fig 1H).
Next, to decipher exactly when FAM83D associates with CK1a
during the cell division cycle, we arrested FAM83DGFP/GFP cells in G2
using the CDK1 inhibitor RO-3306 [21], or in mitosis (M) with STLC
shake-off, and lysed at 0 (M), 2 (M), 4 (G1) and 6 (G1) hours after
STLC washout (Fig 1I). Cell cycle stages were assigned by monitor-
ing the levels of cyclin B1 (high in M) and cyclin A2 (high in G2), as
well as flow cytometry (Fig 1I and J). CK1a was only detected in
anti-GFP IPs from the mitotic extracts, but not from G2-arrested, G1
or asynchronous extracts (Fig 1I). As observed before, FAM83D-
GFP displayed a robust mobility shift only in the mitotic samples
(Fig 1I). To test whether the mitotic FAM83D–CK1a interaction
occurs in other mammalian cells, we expanded our interaction anal-
ysis to include three additional human cell lines, namely cervical
cancer HeLa, lung adenocarcinoma A549 and human keratinocyte
HaCaT. Endogenous FAM83D protein immunoprecipitated from
these cells in STLC-synchronised mitotic extracts also co-precipi-
tated CK1a (Fig 1K). As in U2OS cells, FAM83D also displayed a
pronounced electrophoretic mobility shift in mitotic extracts isolated
from these cell lines (Fig 1K).
We sought to probe the mitosis-dependent nature of the
FAM83D–CK1a interaction further. Given that the N-terminal
DUF1669 of FAM83 proteins mediates CK1a binding [12], we
reasoned that the C-terminus of FAM83D may act in an auto-
inhibitory manner to prevent CK1a binding until mitosis. In
agreement with this hypothesis, isolated FAM83D C-terminal
fragments lacking the DUF1669 co-precipitate N-terminal
FAM83D fragments, yet do not co-precipitate CK1a (Fig EV2A). In
contrast, the N-terminal DUF1669-containing fragment of FAM83D
co-precipitated CK1a even under asynchronous conditions
(Fig EV2B), suggesting that the DUF1669 of FAM83D is both
necessary and sufficient to interact with CK1a, and that during
mitosis the autoinhibitory effect of the FAM83D C-terminal
fragment on the DUF1669 is relieved.
FAM83D recruits CK1a to the mitotic spindle
We sought to test whether FAM83D and CK1a interact and co-
localise in cells during mitosis. In mitotic FAM83DGFP/GFP cells,
we observed complete overlapping signals between the FAM83D-
GFP fluorescence and endogenous CK1a immunofluorescence (IF)
signals on the STLC-induced monopolar mitotic spindles (Fig 2A,
top panel). In wild-type cells, which express FAM83D without the
GFP tag, we also observed CK1a on mitotic spindles (Fig 2A,
middle panel). Strikingly, consistent with our hypothesis that
FAM83 proteins recruit CK1 isoforms to distinct cellular sites, no
CK1a signal was evident on the spindle apparatus in FAM83D/
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U2OS cells (Fig 2A; lower panel), suggesting FAM83D recruits
CK1a to the spindle in mitosis. No CK1e staining was detected at
the spindle apparatus in either the wild-type, FAM83D/ or
FAM83DGFP/GFP cells (Fig EV2C), highlighting the specificity of the
FAM83D–CK1a interaction. HMMR, which is responsible for
recruiting FAM83D to the spindle in mitosis [16], was observed
at the spindle in wild-type, FAM83D/ and FAM83DGFP/GFP cells
(Fig EV2D).
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Figure 1.
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We previously identified two conserved residues (equivalent to
D249 and F283 of FAM83D) within the conserved DUF1669 of FAM83
proteins that were critical for mediating the FAM83–CK1 interaction
[12]. GFP-tagged wild-type FAM83D, but not F283A or D249A
mutants, co-precipitated endogenous CK1a during mitosis when
transiently expressed in FAM83D/ cells (Fig EV3A). Interestingly,
we noted that the mitotic electrophoretic shift evident for wild-type
GFP-FAM83D was absent for the two mutants (Fig EV3A), suggest-
ing that CK1a binding is required for the mitotic mobility shift
evident in FAM83D. To validate these findings at the endogenous
level, we generated U2OS knockin cell lines harbouring the F283A
mutation on FAM83D as well as a GFP tag at the C-terminus (here-
after referred to FAM83DGFP/GFP(F283A), Fig EV1) using CRISPR/Cas9,
and verified homozygous knockins by DNA sequencing. Excitingly,
like FAM83D/ cells, no endogenous CK1a IF signal was detected
on the spindles in these cells, while overlapping GFP and CK1a
signals were observed in FAM83DGFP/GFP cells (Fig 2B). However,
FAM83D(F283A)-GFP still localised to the mitotic spindle, albeit
with relatively less GFP fluorescence intensity compared to
FAM83D-GFP (Fig 2B). Quantification of the CK1a IF signal on the
mitotic spindle from these cells corroborated these observations
(Fig 2C). Furthermore, endogenous CK1a was detected only in GFP
IPs from mitotic FAM83DGFP/GFP cell extracts, but not from
mitotic FAM83D/ or FAM83DGFP/GFP(F283A) extracts (Fig 2D). Iden-
tical results were obtained with an independent CRISPR
FAM83DGFP/GFP(F283A) knockin clone, further confirming these
results (Fig EV3B and C). To further ascertain whether CK1a recruit-
ment to the spindle was dependent on the FAM83D protein, we
employed the Affinity-directed PROtein Missile (AdPROM) system
[22,23] to efficiently degrade FAM83D-GFP using VHL fused to an
anti-GFP nanobody (VHL-aGFP.16) (Figs 2E and F, and EV1). In
mitotic FAM83DGFP/GFP cells, and FAM83DGFP/GFP cells expressing
the VHL or aGFP.16 controls, overlapping GFP fluorescence and
endogenous CK1a IF signals were evident. In contrast, both signals
disappeared from mitotic spindles in mitotic FAM83DGFP/GFP cells
expressing the VHL-aGFP.16 AdPROM, which resulted in FAM83D-
GFP degradation (Fig 2F and G).
Finally, we rescued the FAM83D/ U2OS cells by knocking in a
polycistronic cassette, consisting of wild-type FAM83D cDNA, an
IRES element, GFP reporter and polyadenosine tail, directly down-
stream of the endogenous FAM83D promoter (Figs 3A and EV1) and
obtained and verified two rescue clones by DNA sequencing and
immunoblotting (Fig 3B). In both clones, we verified that the
expression of the FAM83D protein and its mitotic phospho-mobility
shift closely mirrored that seen in wild-type cells; however, the
expression of FAM83D in clone 11 was slightly lower than that
observed in clone 6 (Fig 3B). Next, we verified that both FAM83D
(Fig 3C) and CK1a (Fig 3D and E) localised to the spindle apparatus
in both FAM83D-rescue clones, similar to that observed in wild-type
cells. Finally, we also confirmed that the reinstated FAM83D in both
clones co-precipitated endogenous CK1a only in mitosis (Fig 3F).
FAM83D and CK1a in unperturbed cells
In order to determine endogenous FAM83D and CK1a co-localisation
at different phases of mitosis in the absence of any drug-induced cell
synchronisation, we first knocked in an mCherry tag onto either the
CSNK1A1 gene (CK1a) or the CSNK1E gene (CK1e) in FAM83DGFP/GFP
U2OS cells by CRISPR/Cas9 (Fig EV1), and verified homozygous
insertions by immunoblotting and IPs (Fig EV4A and B), as well as
genomic DNA sequencing. After confirming that the mCherry tag
did not render CK1a inactive (Fig EV4C), we performed fluores-
cence microscopy on these cells. We observed robust overlapping
centrosomal and mitotic spindle fluorescence between FAM83D-
GFP and mCherry-CK1a from prometaphase all the way to
anaphase, with less intense co-fluorescence evident in the latter
stages of mitosis (Fig 3G). In contrast, we did not observe spindle
localisation of mCherry-CK1e, nor co-localisation with FAM83D-GFP
(Fig EV4D), at any stage of mitosis.
FAM83D regulation during the cell cycle
The ~25 kDa electrophoretic mobility shift evident for mitotic
FAM83D-GFP collapsed substantially when the FAM83D-GFP IPs
◀ Figure 1. FAM83D and CK1a interact only in mitosis.A Immunoblot analysis of wild-type (WT), FAM83D/ knockout (KO) and FAM83DGFP/GFP knockin (KI) U2OS cell lines.
B Proteomic analysis on asynchronous (AS), nocodazole- or STLC-synchronised mitotic (M) FAM83DGFP/GFP knockin (KI) U2OS cells. The Venn diagram depicts the top
proteins which were identified as FAM83D interactors in AS, M or both AS and M conditions, in both nocodazole and STLC treatments (for a detailed analysis
procedure, see the Materials and Methods section).
C Schematic highlighting whether a mitotic interaction was previously known between FAM83D and the interacting proteins identified in (B).
D AS or nocodazole-synchronised M KI cells were lysed and subjected to GFP TRAP immunoprecipitations (IP). Extracts (input) and IP samples were analysed by
immunoblotting (IB) with the indicated antibodies.
E KI cells synchronised in mitosis with either nocodazole (M Noc.) or STLC (M STLC) were collected by shake-off, and drug-treated cells that remained adherent after
shake-off (AS Noc.; AS STLC) were lysed and subjected to GFP TRAP IP. AS cells and free GFP-expressing 2G-PAI1 U2OS cells were included as controls. Input and IP
samples were analysed by IB with the indicated antibodies.
F Propidium iodide staining analyses revealing cell cycle distribution profiles for the samples described in (E).
G, H AS or nocodazole-synchronised (M) WT U2OS cells were subjected to IP with IgG and either anti-FAM83D-coupled sepharose beads (G), or anti-CK1a-coupled
sepharose beads (H). Input and IP samples were analysed by IB with the indicated antibodies.
I KI cells were synchronised in G2 with RO-3306, or arrested in mitosis (M) using STLC. STLC-treated shake-off cells were washed and re-plated, and cells lysed at the
indicated time points after STLC washout. Cell lysates were subjected to GFP TRAP IP and input and IP extracts analysed by IB with the indicated antibodies.
J Propidium iodide staining analyses revealing cell cycle distribution profiles for the samples described in (I).
K AS or STLC-synchronised (M) HeLa, A549 and HaCaT cells were subjected to IP with either IgG- or anti-FAM83D-coupled sepharose beads. Input and IP samples
were analysed by IB with the indicated antibodies.
Data information: All blots are representative of at least three independent experiments.
Source data are available online for this figure.
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were subjected to k-phosphatase treatment, almost to the level of
FAM83D-GFP in asynchronous cells (Fig 4A), suggesting that this
mobility shift was due to phosphorylation. Using the mobility shift
as a readout, we investigated FAM83D phosphorylation over the
course of a cell division following release from STLC arrest. As
expected, there was a reduction in levels of cyclin B1 and phospho-
histone H3 phosphorylation as cells progressed through mitosis
[24,25], indicating that cells started exiting mitosis around 2 h after
STLC washout (Fig 4B). Interestingly, concurrent reduction in the
levels of both HMMR and phospho-FAM83D was observed, suggest-
ing that both proteins are regulated in a cell cycle-dependent
manner (Fig 4B). Such patterns in the levels of cell cycle-regulated
proteins are often associated with their degradation following
mitotic exit, or during the metaphase-to-anaphase transition [25,26].
Interestingly, the protein levels of CK1a did not change after the
STLC washout (Fig 4B). Considering that both FAM83D and CK1a
A
D F G
E
B C
Figure 2. FAM83D recruits CK1a to the spindle.
A STLC-synchronised mitotic (M) wild-type (WT), FAM83D/ knockout (KO) and FAM83DGFP/GFP knockin (KI) U2OS cells were subjected to anti-CK1a
immunofluorescence and GFP fluorescence microscopy. DNA is stained with DAPI. Scale bars, 20 lm.
B STLC-synchronised mitotic (M) FAM83D/ knockout (KO), FAM83DGFP/GFP knockin (KI) and FAM83DGFP/GFP(F283A) knockin (FA) U2OS cells were subjected to anti-CK1a
immunofluorescence and GFP fluorescence microscopy. DNA is stained with DAPI. Scale bars, 20 lm.
C Quantification of CK1a spindle localisation for the cells described in panels (A and B). Cell images denote the measured regions used to calculate the ratios on the box
plot. Box plot whiskers denote the minimum and maximum measured values. The middle line represents the median, and the box ranges depict the 25th/75th
percentiles. ***P < 0.0001; ANOVA. Analysis was performed on the indicated number of cells, n = 2.
D The cell lines described in (B) were STLC-synchronised and mitotic cells (M) isolated by shake-off. Asynchronous (AS) cells were included as a control. Cells were lysed
and subjected to GFP TRAP immunoprecipitation (IP) and subsequent immunoblotting (IB) with the indicated antibodies.
E Schematic illustration of the AdPROM-mediated degradation of FAM83D. VHL; Von Hippel-Lindau protein, CUL2; cullin 2, RBX1; RING-box protein 1, E2; E2 ubiquitin-
conjugating enzyme, aGFP.16; anti-GFP.16 nanobody.
F KI cells were infected with retroviruses encoding either VHL, aGFP.16 or VHL-aGFP.16. Uninfected cells were used as a control. Cells were lysed and subjected to IB
with the indicated antibodies.
G The cell lines described in (F) were subjected to anti-CK1a immunofluorescence and GFP fluorescence microscopy. DNA is stained with DAPI. Scale bars, 20 lm.
Data information: All blots are representative of at least three independent experiments.
Source data are available online for this figure.
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appear to dissociate from the spindle following the metaphase-to-
anaphase transition (Fig 3G), it appears likely that following
FAM83D degradation, CK1a can no longer localise to the spindle,
and dissociates into the cytosol. The reduction in FAM83D and
HMMR protein levels following STLC washout was blocked with
MG132 (Fig 4C), suggesting that FAM83D and HMMR potentially
undergo proteasomal degradation upon mitotic exit. Cyclin B1 levels
were also rescued by MG132 treatment (Fig 4C). As MG132 is also
known to inhibit the metaphase-to-anaphase transition through the
stabilisation of the anaphase-promoting complex/cyclosome (APC/C)
E3 ligase substrate securin [25], this transitional delay could in turn
explain the lack of phospho-FAM83D and HMMR degradation.
Indeed, analogous results on phospho-FAM83D and HMMR stabili-
sation were observed when mitotic cells were released into medium
containing the APC/C inhibitor ProTAME [27] (Fig 4D). The CK1a
protein levels were unaffected by either MG132 or ProTAME
A
C
G
D
E
F
B
Figure 3.
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treatments (Fig 4C and D). Next, we sought to confirm that the
mitotic post-translational machinery triggers FAM83D degradation
in cells. First, we arrested U2OS cells in mitosis with STLC and
isolated them by shake-off. Mitotic cells were released into medium
containing either the CDK1 inhibitor RO-3306 or dimethyl sulfoxide
(DMSO) vehicle control, in the presence or absence of the proteaso-
mal inhibitor MG132. Forced mitotic exit caused by CDK1 inhibition
resulted in robust FAM83D, HMMR and cyclin B1 degradation,
whereas addition of MG132 blocked their proteolysis (Fig 4E),
thereby confirming that it is the mitotic post-translational machinery
that regulates FAM83D stability as cells progress through mitosis.
Transcriptional analysis by qRT–PCR showed a significant twofold
increase in FAM83D and HMMR transcript levels in mitotic over
asynchronous cells (Fig 4F), suggesting that both FAM83D and
HMMR are cell cycle-regulated genes, similar to CCNB1 transcripts
[28] (Fig 4F). We did not detect any significant difference in CK1a
transcript levels between asynchronous and mitotic cells (Fig 4F).
The synergistic regulation of FAM83D and HMMR, along with
their constitutive interaction, suggested a possible role for HMMR in
the regulation of FAM83D and CK1a in mitosis (Fig 4G). Indeed, as
observed in U2OS cells, a robust mitotic phospho-FAM83D mobility
shift was evident in wild-type MEFs, but this shift was completely
absent in the HMMR knockout MEFs [15] (Fig 4H). This is consis-
tent with the notion that HMMR directs FAM83D to the spindle [16],
and hence, in the absence of HMMR, FAM83D no longer localises to
the mitotic spindle and is not phosphorylated. If this were the case,
one would expect that CK1a should not be recruited to the mitotic
spindle in HMMR knockout MEFs. After first confirming HMMR
localises to the spindle in the wild-type but not HMMR knockout
MEFs (Fig 4I), we observed robust CK1a mitotic spindle localisation
in wild-type MEFs, but could not detect CK1a on the mitotic spindle
in HMMR knockout MEFs (Fig 4J). Collectively, these data support
the model where HMMR directs FAM83D to the spindle apparatus
in mitosis, and subsequently, FAM83D recruits CK1a through the
DUF1669. Furthermore, these findings show that the mitotic phos-
pho-dependent mobility shift observed for FAM83D relies on the
recruitment of CK1a to the mitotic spindle.
The role of CK1a in FAM83D phosphorylation
Given the absence of the FAM83D(F283A)-GFP mitotic mobility shift
despite its mitotic localisation (Fig 2B and D), we wondered
whether targeted delivery of CK1a to FAM83D(F283A)-GFP by an
anti-GFP nanobody (aGFP.16) could artificially reconstitute the
FAM83D–CK1a interaction and restore the phospho-shift (Figs 5A
and EV1). Excitingly, expression of aGFP.16-CK1a in
FAM83DGFP/GFP(F283A) cells rescued the phospho-mobility shift of
FAM83D(F283A)-GFP, regardless of whether the cells were in mitosis
or not (Fig 5B). We also observed robust association of aGFP.16-
CK1a with FAM83D(F283A)-GFP in anti-GFP IPs (Fig 5B). During the
course of these experiments, we noticed that this rescued FAM83D
(F283A)-GFP mobility shift was slightly smaller than the mitotic
mobility shift of wild-type FAM83D-GFP (Fig 5B). Thus, to confirm
that aGFP.16-CK1a was not phosphorylating random residues on
FAM83D, we repeated this experiment in wild-type FAM83DGFP/GFP
U2OS cells (Fig EV5A). As with FAM83D(F283A)-GFP, we observed
constitutive FAM83D-GFP phosphorylation regardless of cell cycle
stage, but the aGFP.16-CK1a-induced band-shift migrated to the same
level as the mitotic FAM83D-GFP shift in control cells (Fig EV5A). As
we do not observe any larger mitotic mobility shifts when wild-type
FAM83D is phosphorylated by aGFP.16-CK1a, we attribute the slight
reduction in mobility seen with the aGFP.16-CK1a-rescued FAM83D
(F283A)-GFP mutant to potential conformational defects resulting
from the F283A mutation, potentially occluding one or more of the
phospho-acceptor residues from aGFP.16-CK1a.
The mobility shift of FAM83D(F283A)-GFP restored by the
targeted delivery of CK1a relied on CK1a catalytic activity as two
catalytically inactive mutants of CK1a (K46D and D136N) failed to
rescue this phospho-shift completely (Fig 5C). Critically, we
observed robust co-localisation between FAM83D and CK1a on
intact mitotic spindles (Fig 5D). However, under conditions where
CK1a phosphorylated FAM83G in vitro, it failed to phosphorylate
recombinant FAM83D (Fig EV5B), suggesting a cellular FAM83D
context or a priming phosphorylation event might be required for
FAM83D phosphorylation by CK1a. Interestingly, when wild-type
CK1e, which does not interact with FAM83D nor localise to the
spindle, is delivered to FAM83D(F283A)-GFP by aGFP.16, it too
rescued the FAM83D phospho-shift (Fig EV5C), suggesting the prox-
imal catalytic activity of CK1 is sufficient for the phospho-shift and
highlights the notion that subcellular localisation and substrate
association are important determinants for CK1 targets.
By delivering CK1a to the mitotic spindle, it is likely that
FAM83D directs CK1a to phosphorylate many mitotic substrates,
including itself. However, this hypothesis relies on CK1a being
◀ Figure 3. Reinstating FAM83D at the endogenous locus in FAM83D knockout cells.A Schematic illustrating the CRISPR-based strategy used to reintroduce FAM83D into the FAM83D/ knockout background.
B FAM83D/ (KO), wild-type (WT) and two independent clones from a CRISPR/Cas9-mediated knockin rescue of FAM83D cDNA into FAM83D/ cells (c. 6 and c. 11)
were synchronised in mitosis (M) with STLC. Asynchronous (AS) cells were included as a control. Cells were lysed and subjected to immunoblotting (IB) with the
indicated antibodies.
C, D The cell lines described in (B) were STLC-synchronised in mitosis, fixed and stained with antibodies recognising FAM83D (C) or CK1a (D). Representative images of
mitotic cells are included. Scale bars, 20 lm.
E Quantification of CK1a spindle localisation for the experiment described in (D) using the same strategy employed in Fig 2C. Box plot whiskers denote the minimum
and maximum measured values. The middle line represents the median, and the box ranges depict the 25th/75th percentiles. ***P < 0.0001; ANOVA. Analysis was
performed on the indicated number of cells, n = 1.
F The cell lines described in (B) were STLC-synchronised in mitosis (M) or left AS, lysed and subjected to immunoprecipitation (IP) with anti-FAM83D-coupled
sepharose beads, before IB with the indicated antibodies.
G Asynchronous (AS) FAM83DGFP/GFP/mCherry/mCherryCSNK1A1 knockin U2OS cells were fixed and imaged. Representative images from the indicated cell cycle stages are
included. Scale bars, 10 lm. All blots are representative of at least three independent experiments.
Data information: All blots are representative of at least three independent experiments.
Source data are available online for this figure.
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functionally active when bound to FAM83D in mitosis. To test this,
we employed an IP-based kinase assay strategy to isolate the
FAM83D–CK1a complex, and measure phosphorylation of an
optimised CK1 substrate peptide (CK1tide) using [c-32P]-ATP
(Fig 5E). Excitingly, when anti-GFP IPs from asynchronous and mitotic
extracts from FAM83D/, FAM83DGFP/GFP and FAM83DGFP/GFP(F283A)
A
D
G
H I J
E
F
B C
Figure 4. FAM83D regulation during the cell cycle.
A Nocodazole-synchronised mitotic FAM83DGFP/GFP knockin U2OS cells were lysed and subjected to GFP TRAP immunoprecipitation (IP), followed by incubation
 k-phosphatase. Asynchronous (AS) cells were used as a control. Whole-cell extracts (input) and IP samples were subjected to SDS–PAGE and subsequent
immunoblotting (IB) with the indicated antibodies.
B–D STLC-synchronised mitotic wild-type U2OS cells were lysed at the indicated time points following STLC washout and release into medium (B), medium  MG132
(C) or medium  ProTAME (D). AS cells were used as a control. Lysed extracts were subjected to IB with the indicated antibodies.
E Wild-type U2OS cells were either left asynchronous (AS), or arrested in mitosis with STLC and collected by shake-off (M). AS and M cells were incubated in media
containing combinations of RO-3306 and MG132 as indicated, prior to lysis. MG132 was applied for 1.5 h, whereas RO-3306 was applied for the last 1 h of
incubation prior to lysis. Samples were lysed and extracts were subjected to SDS–PAGE, before IB with the indicated antibodies.
F STLC-synchronised mitotic wild-type U2OS cells were subjected to qRT–PCR analysis using primers for FAM83D, HMMR, CSNK1A1 and CCNB1. AS cells were used as
a control. Error bars, SEM; *P < 0.01; Student’s t-test. n = 3.
G Schematic representing the predicted effects of HMMR knockout on FAM83D–CK1a delivery to the mitotic spindle. In the absence of HMMR, no FAM83D and, by
extension, no CK1a can localise to the spindle.
H STLC-synchronised mitotic wild-type (WT) and HMMR knockout (KO) mouse embryonic fibroblasts (MEFs) were lysed and subjected to IB with the indicated
antibodies. AS cells were included as a control.
I, J The cells described in (H) were STLC-synchronised in mitosis and subjected to immunofluorescence microscopy with an anti-HMMR antibody (I) or an anti-CK1a
antibody (J). DNA is stained with DAPI. Scale bars, 20 lm.
Data information: All blots are representative of at least three independent experiments.
Source data are available online for this figure.
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cell lines were subjected to kinase assays against CK1tide, only
those from mitotic FAM83DGFP/GFP extracts, which co-precipitated
endogenous CK1a, displayed significant phosphorylation of CK1tide
(Fig 5F).
The FAM83D–CK1a complex regulates spindle positioning
Separately, FAM83D and CK1a have been implicated in mitotic reso-
lution and spindle/chromosome alignment [16,17,29,30]. So, we
A B
C
E F
D
Figure 5.
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sought to test whether FAM83D and CK1a act in the same pathway
in mitosis. Time lapse microscopy (Fig 6A) showed that, compared
to wild-type and FAM83DGFP/GFP knockin cells, there was a signifi-
cant metaphase-to-anaphase transitional delay in the FAM83D/
and FAM83DGFP/GFP(F283A) cell lines (Fig 6B and C). When we anal-
ysed spindle orientation in these cells, we noted that in subconfluent
FAM83D/ and FAM83DGFP/GFP(F283A) cells, which are both defi-
cient for spindle localisation of CK1a, spindles oriented at a fixed
angle (Fig 6D, yellow lines), which is consistent with the phenotype
described following siRNA depletion of FAM83D [16]. The position
of the cell division axis at anaphase, relative to its expected position
aligned with the long cell axis in interphase, showed significant
deviation in FAM83D/ and FAM83DGFP/GFP(F283A) cells compared
to wild-type and FAM83DGFP/GFP cells (Fig 6D and E). Excitingly,
this phenotype in FAM83D/ cells was rescued when FAM83D
cDNA was restored at the endogenous FAM83D locus, with full
rescue observed when restored FAM83D expression was compara-
ble to that of wild-type cells (rescue clone 6) and a partial rescue
observed when restored FAM83D expression was lower than that of
wild-type cells (rescue clone 11) (Fig 6D and E). To better study the
process of spindle orientation in individual cells, we seeded individ-
ual wild-type, FAM83D/, FAM83DGFP/GFP or FAM83DGFP/GFP(F283A)
U2OS cells onto L-shaped fibronectin-coated micropatterns, which
cause cells to position their spindle on a defined axis [31], and
measured the spindle orientation angles. Whereas wild-type and
FAM83DGFP/GFP cells orientated their spindles along the defined,
predicted axes, we observed significant deviations in the predicted
spindle orientation axes with FAM83D/ and FAM83DGFP/GFP(F283A)
cells (Fig 6F and G), with nearly 80% unable to orientate their spin-
dles correctly (Fig 6H) (for representative movies for each cell line,
see Movies EV1–EV8). Again, this phenotype in the FAM83D/
cells was fully rescued in FAM83D cDNA knockin rescue clone 6,
and partially in clone 11 (Fig 6G and H).
During the process of spindle positioning analyses, we observed
a random orientation of the initial spindle position (Fig 6G), which
is normally directed by the position of retraction fibres [32] and the
assembly of subcortical actin [33,34]. To monitor actin dynamics
during the process of spindle assembly and orientation, cells were
transfected with actin-Red Fluorescent Protein (RFP) prior to seed-
ing on L-shaped micropatterns. In wild-type cells, we observed
polarised subcortical actin adjacent to the right angle of the L-shape
following DNA condensation through to anaphase (Fig 6I).
However, actin appeared to be randomly organised with respect to
the micropattern in FAM83D/ and FAM83DGFP/GFP(F283A) cells
during the spindle assembly process (Fig 6J). This observation in
FAM83D/ cells was rescued in FAM83D cDNA knockin clone 6,
and partially in clone 11 (Fig 6J). FAM83DGFP/GFP cells organised
their actin in a manner comparable with wild-type cells (Fig 6J).
The targeted delivery of wild-type (WT) or kinase-dead (KD)
CK1a to FAM83D(F283A)-GFP in knockin cells, notwithstanding the
potential caveats of overexpression, allowed us to explore the role
of CK1a catalytic activity in metaphase length and spindle orienta-
tion. Delivery of both WT and KD aGFP.16-CK1a resulted in
shortening of the metaphase delay observed in FAM83DGFP/GFP(F283A)
cells (Fig 6A–C). However, the spindle orientation defect in
FAM83DGFP/GFP(F283A) cells was rescued completely with aGFP.16-CK1a,
whereas only partially with the kinase-dead aGFP.16-CK1a, in
both subconfluent cultures (Fig 6D and E) and L-shaped micro-
patterns (Fig 6G and H). Actin was correctly polarised in
FAM83DGFP/GFP(F283A) cells rescued with WT, but not with the KD
aGFP.16-CK1a (Fig 6J). Interestingly, we observed similar spindle
positioning and actin cytoskeletal defects when CK1a was knocked
down using siRNA oligonucleotides (Appendix Fig S1), reinforcing
the notion that FAM83D and CK1a act together in mitosis.
We also observed frequent plasma membrane blebbing on one
of the daughter cells in FAM83D/ and FAM83DGFP/GFP(F283A)
cells at the latter stages of mitosis (red arrows in Fig 6F). This
phenomenon, known as asymmetric membrane elongation
(AME), is a compensatory mechanism to ensure equal distribution
of cell size following mitosis, when the spindle is misorientated
[35]. Live cell microscopy confirmed blebbing in FAM83D/ and
FAM83DGFP/GFP(F283A) cells but not in wild-type, or FAM83DGFP/GFP
cells, or in both clones rescued through knockin of FAM83D cDNA
into the endogenous FAM83D locus in FAM83D/ background
(Appendix Fig S2). Reduction of blebbing in FAM83DGFP/GFP(F283A)
cells to levels seen in wild-type cells was observed when cells
were rescued with WT aGFP.16-CK1a, whereas an intermediate
phenotype was observed with the KD aGFP.16-CK1a rescue
(Appendix Fig S2). Importantly, there was no difference in daugh-
ter cell size between all cell lines (Appendix Fig S2). Taken
together, these data indicate the FAM83D–CK1a interaction is
critical for timely mitotic progression, including the processes of
establishing and orienting both the mitotic spindle and the cell
division axis.
◀ Figure 5. The role of CK1a in FAM83D phosphorylation.A Schematic representation of the anti-GFP nanobody (aGFP.16)-based targeting strategy used to deliver CK1a to the CK1-binding-deficient FAM83D(F283A)-GFP
mutant.
B STLC-synchronised mitotic FAM83DGFP/GFP knockin (KI), FAM83DGFP/GFP (F283A) (FA) and FAM83DGFP/GFP(F283A) stably expressing aGFP.16-CK1a (FA + aGFP.16-CK1a) U2OS
cells were subjected to GFP TRAP immunoprecipitation (IP), followed by immunoblotting (IB) with the indicated antibodies. Asynchronous (AS) cells were used as
controls.
C FA cells were infected with retroviruses encoding wild-type aGFP.16-CK1a (WT), or aGFP.16-CK1a with one of two distinct CK1a kinase-inactive mutants (D136N or
K46D). Uninfected cells () were included as a control. Cells were lysed, subjected to anti-GFP IP and IB with the indicated antibodies.
D Immunofluorescence analysis for the cells described in (B) following synchronisation with STLC. Cells were stained using anti-CK1a antibody, and DNA is stained with
DAPI. Scale bars, 20 lm.
E Schematic depicting the IP kinase assay strategy used to test whether FAM83D-bound CK1a was catalytically active.
F FAM83D/ knockout (KO), KI and FA cells were synchronised in mitosis (M) using STLC. Lysed extracts were subjected to anti-GFP IPs, followed by [c32P]-ATP kinase
assays, using an optimised CK1 substrate peptide (CK1tide). AS cells were used as controls. Error bars, SEM; P < 0.01; ANOVA. n = 3. Input and IP samples were
analysed by IB with the indicated antibodies.
Data information: All blots are representative of at least three independent experiments.
Source data are available online for this figure.
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Discussion
Correctly orientated cell division, achieved through proper spindle
positioning, is crucial for both normal development and mainte-
nance of healthy tissues [36–39]. By conclusively placing CK1a at
the mitotic spindle to ensure proper spindle orientation and timely
passage through mitosis, our study adds a new paradigm to the
phospho-control of mammalian cell division. Interestingly, the
mechanism by which the cell cycle-regulated protein FAM83D medi-
ates the delivery of CK1a to the mitotic spindle draws parallels with
how TPX2 recruits and regulates Aurora A during mitosis. While
interactors of FAM83D, including HMMR and DYNLL1, offer
insights into how FAM83D localises to the mitotic spindle to recruit
CK1a, the full extent of CK1a substrates that potentially mediate
proper spindle positioning to ensure error-free progression through
mitosis remain to be defined. Furthermore, exactly how the spindle-
localised FAM83D–CK1a complex can regulate the spatially distinct,
yet not unrelated, actin cytoskeleton remains to be determined.
However, phosphorylation of distinct substrates by CK1a may trig-
ger their translocation from the spindle to the actin network directly
or indirectly. Nonetheless, the findings that the FAM83D–CK1a
complex acts at the mitotic spindle add to the evidence for intricate
subcellular regulation of CK1 isoforms, which are implicated in
many cellular processes from Wnt signalling to the regulation of
circadian rhythms, by FAM83 proteins [13].
Given the participation of CK1 isoforms in such diverse biological
processes, it is perhaps not surprising that some studies have
explored and reported on roles for CK1a in the cell division cycle.
Specifically, injection of CK1a antibodies into developing mouse
embryos resulted in a significant delay in the progression to the first
mitotic cleavage [29] and injection of CK1a morpholinos in mouse
oocytes resulted in meiotic chromosomal alignment and congression
defects [30]. However, these studies lacked any mechanistic under-
standing of how CK1a carried out these functions, as did the studies
that reported somewhat similar phenotypes resulting from siRNA
knockdown of FAM83D in cells [16,17]. Interestingly, CK1 activity
in Caenorhabditis elegans embryos was shown to regulate spindle
positioning through regulation of cortical force generation [40].
However, as FAM83D and the other FAM83 proteins are not
conserved in invertebrates, there is likely to be an alternative way
in which CK1 regulates spindle positioning in invertebrates. Here,
our findings that FAM83D binds and recruits CK1a to the mitotic
spindle for proper spindle positioning illuminate mechanistic
insights into the role and regulation of CK1a in mitosis, and estab-
lish that CK1a catalytic activity at the mitotic spindle is required for
smooth and efficient cell division. In support of our findings, it is
also interesting that observations of CK1a at the mitotic spindle
have been noted by immunostaining [41] and large-scale mitotic
spindle proteomic [42] studies.
Beyond CK1a, the phosphorylation-mediated control of spindle
positioning has been attributed to several other protein kinases. Of
note, the activity of CDKs, PLKs and Aurora kinases have all been
shown to critically regulate spindle positioning [15,43–50]. Both
their recruitment to the mitotic spindle and activities are tightly regu-
lated [44,46,51,52]. In the case of PLK1, the centrosomal PLK1 pool
regulates spindle positioning through the PLK1-dependent spindle
positioning pathway, and acts to strip force-generating Dynein
complexes from the cortex when the spindle pole gets too close to
the cortex [37]. PLK1 itself is regulated downstream of CDK1 and
Aurora A, illustrating some of the crosstalk evident between these
mitotic kinases [53]. Thus, the concerted action of mitotic kinases
likely functions within a tightly controlled phospho-network to
ensure the correct and efficient orientation of the mitotic spindle.
Recently, lenalidomide-induced degradation of CK1a was shown
to be effective in the treatment of pre-leukaemic human myelodys-
plastic syndrome (MDS) [54]. Similarly, genetic ablation of CK1a
has been shown to activate the tumour suppressor p53, suggesting
CK1a could make an anti-cancer target [55,56]. Yet, other studies
have demonstrated that CK1 inhibitors stabilise b-catenin and acti-
vate Wnt signalling, which promotes cell proliferation [11,57,58].
Our findings would suggest that the anti-proliferative effects of
CK1a inhibitors might be occurring, in part, through the inhibition
of the mitotic FAM83D-CK1a pool. Often thought of as undruggable
kinases due to their participation in multiple, critical cellular
processes, a method of targeting CK1 isoforms at specific locations
under certain conditions is thus warranted, yet is very challenging.
◀ Figure 6. The FAM83D–CK1a complex regulates spindle positioning.A Representative images initiating at metaphase for mitotic U2OS cell lines stained with Hoechst, taken every 5 min as they progress through division. Mitotic stage
was determined by chromosome condensation and is indicated by the coloured boxes. Scale bar, 20 lm.
B Graphical representation for the kinetics of transition from metaphase alignment (yellow) to anaphase (green), and cytokinesis (blue). 100 mitotic cells per genotype
are plotted; n = 2.
C Length of time needed to transition from metaphase to anaphase. Mean of 100 mitotic cells per genotype are plotted; n = 2. Error bars, SEM. ***P < 0.0001; ANOVA.
D Representative bright-field images for mitotic U2OS cells indicating the long axis during interphase (white line) preceding mitosis, and the division axis determined at
anaphase (yellow line). Scale bar, 20 lm.
E Percentage of oriented divisions for U2OS cells grown in subconfluent cultures. An oriented division axis was defined as being < 30° removed from the long axis of
the interphase cell. Mean of 50 cells per genotype are plotted, n = 2. Error bars, SEM. ***P < 0.0001; ANOVA.
F Representative images of mitotic U2OS cells stained with Hoechst and grown on L-shaped micropatterns previously coated with fibronectin. The position of
metaphase chromosomes, which is plotted in panel (H), is indicated (yellow line) as is the presence of cortical blebbing (red arrows). Scale bar, 20 lm.
G Circular graphs, superimposed on L-shaped micropattern, show the distribution of cell division angles measured at anaphase. Angles for 100 U2OS cells are plotted
per genotype, n = 2. Metaphase position is indicated (yellow line), and the percentages of division angles  15° from the expected axis (red line) are indicated.
H Percentage of metaphase U2OS cells that align chromosomes outside of the expected axis (angles  15°). Mean of 100 cells per genotype are plotted, n = 2. Error
bars, SEM. ***P < 0.0001; ANOVA.
I Representative images of RFP-actin localisation in mitotic U2OS cells grown on fibronectin-coated, L-shaped micropatterns, which is superimposed. Arrowheads
indicate polarised cortical actin. Heatmap shows the intensity of RFP-actin localisation (ImageJ z-projection standard deviation) as the cell progresses from prophase
to metaphase (12–24 min). Scale bar, 20 lm.
J Heatmap additive intensities of RFP-actin localisation in two representative mitotic U2OS cells for each genotype grown on fibronectin-coated, L-shaped
micropatterns. Arrowheads indicate polarised cortical actin.
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However, building on data shown here, it may transpire that target-
ing the FAM83D–CK1a interaction may prove a viable therapeutic
approach aimed at inhibition of proliferation.
Materials and Methods
Plasmids
Recombinant DNA procedures were performed using standard
protocols as described previously [23]. Human wild-type FAM83D,
CSNK1A1, CSNK1E or appropriate mutants were sub-cloned into
pcDNA5/FRT/TO or pBABED P vectors (pBABED P denotes a
Dundee-modified version of the pBABE Puro vector). FAM83D
constructs harbour a Green Fluorescence Protein (GFP) tag at the
N-terminus where indicated. All constructs are available to request
from the MRC-PPU reagents webpage (http://mrcppureagents.d
undee.ac.uk), and the unique identifier (DU) numbers indicated
below provide direct links to sequence information and the cloning
strategy used. The following constructs were generated: pcDNA5-
FRT/TO GFP-FAM83D (DU29092), pcDNA5-FRT/TO GFP-FAM83D
(F283A) (DU29109), pcDNA5-FRT/TO GFP-FAM83D (D249A)
(DU29110), pBABED P aGFP.16-CK1a (DU29403), pBABED P
aGFP.16-CK1a (K46D) (DU29555), pBABED P aGFP.16-CK1a
(D136N) (DU28707), pBABED P aGFP.16-CK1e (DU29613) and
pBABED P aGFP.16-CK1e (D128N) (DU29629). The AdPROM
constructs used in this study have been described previously [22,23].
Constructs were sequence-verified by the DNA Sequencing Service,
University of Dundee (http://www.dnaseq.co.uk). For amplification
of plasmids, 1 ll of the plasmid was transformed into 10 ll of Escher-
ichia coli DH5a competent bacteria (Invitrogen) on ice, incubated at
42°C for 45 s and then returned to ice for 2 min, before plating on
LB-agar medium plate containing 100 lg/ml ampicillin. LB plates
were inverted and incubated for 16 h at 37°C. Following incubation,
a single colony was picked and used to inoculate 4 ml of LB medium
containing 100 lg/ml ampicillin. Cultures were grown for 18 h at
37°C in a bacterial shaker (Infors HT). Plasmid DNA was purified
using a Qiagen mini-prep kit as per the manufacturer’s instructions.
The isolated DNA yield was subsequently analysed and quantified
using a Nanodrop 1,000 spectrophotometer (Thermo Scientific).
For CRISPR/Cas9 gene editing, the following guide RNAs (gRNA)
and donor constructs were generated: FAM83D knockout: sense
gRNA (DU52007), antisense gRNA (DU52023). FAM83D C-terminal
GFP knockin: sense gRNA (DU54048), antisense gRNA (DU54054),
GFP donor (DU54198). FAM83D C-terminal GFP knockin with
F283A mutation: sense gRNA (DU57831), antisense gRNA
(DU57835), GFP donor (DU57512). FAM83D restoration in the
knockout background: sense gRNA (DU60528), antisense gRNA
(DU60530), FAM83DcDNA-IRES-GFP-polyA donor (DU60707).
CSNK1A1 N-terminal mCherry knockin: sense gRNA (DU57522),
antisense gRNA (DU57527), mCherry donor (DU57578). CSNK1E N-
terminal mCherry knockin: sense gRNA (DU54377), antisense gRNA
(DU54383), mCherry donor (DU57623).
Cell culture
Human osteosarcoma U2OS, cervical cancer HeLa, lung adenocarci-
noma A549, keratinocyte HaCaT or mouse embryonic fibroblasts
(MEF) cells were grown in Dulbecco’s modified Eagle’s medium
(DMEM; Gibco) containing 10% (v/v) Foetal Bovine Serum (FBS;
Hyclone), penicillin (100 U/ml; Lonza), streptomycin (0.1 mg/ml;
Lonza) and L-glutamine (2 mM; Lonza), and cultured at 37°C, 5%
CO2 in a humidified tissue culture incubator. The wild-type and
HMMR knockout MEFs were generated by the Maxwell laboratory
and have been described previously [15]. MEFs were immortalised
using simian virus 40 (SV40) retrovirus, to enable progression
through the cell cycle. All cells used in this study were verified to be
free from mycoplasma contamination. Cells were exposed to dif-
ferent stimuli and compounds as described in the appropriate figure
legends prior to lysis. For transient transfections, cells were trans-
fected for 24 h with 2 lg cDNA (per 10-cm dish) in serum free
OptiMem (Gibco) with the transfection reagent polyethylenimine
(PEI) as described previously [22,23,59]. For retroviral-based infec-
tions, cells were infected with retroviruses as described previously
[22,23].
Cell synchronisation
For synchronisation, cells were arrested at prometaphase with
nocodazole (100 ng/ml) for 12 h, before floating mitotic cells were
isolated through mitotic shake-off. Collected mitotic cells were
washed 3× in PBS before re-plating in fresh full medium for
45 min before lysis, to allow them to progress into mitosis. Alter-
natively, cells were synchronised in mitosis using the Eg5 inhibitor
S-trityl L-cysteine (STLC) [18] (5 lM) for 16 h. Following incuba-
tion, mitotic cells were isolated through shake-off and were either
washed 3× in PBS and re-plated into fresh medium, or washed 2×
in ice-cold PBS, and lysed. Where appropriate, MG132 and
ProTAME were used at 20 lM final concentration. For G2 arrest,
cells were treated with 10 lM of the CDK1 inhibitor RO-3306 [21]
for 24 h before lysis. To trigger forced mitotic exit once cells were
already in mitosis, cells were treated with 10 lM RO-3306 for 1 h
prior to lysis.
Live cell imaging
U2OS cells were grown in 96-well plates (Corning) and imaged for
up to 24 h at 37°C in a 5% CO2 environmental chamber using a 40×
0.75 NA dry objective with the MetaXpress 5.0.2.0 software (Molec-
ular Devices Inc.) on the ImageXpress Micro XL epifluorescence
microscope (Molecular Devices Inc.). For the analysis of cell divi-
sion kinetics, cells were stained with Hoechst (1 lg/ml) to label
DNA and images were taken every 5 min, and movies were made in
the MetaXpress 5.0.2.0 software (Molecular Devices Inc.). For actin
localisation, U2OS cells were seeded at 20% confluency in 24-well
plates, and 1 ll CellLight Actin-RFP (Thermo Fisher Scientific) was
added per 5,000 cells and incubated at 37°C for 16 h. Following the
incubation, U2OS cells were seeded on L-shaped micropatterns
(CYTOO) at 30,000 per ml. For the analysis of actin localisation,
images were taken every 2 min, and movies were made in the
MetaXpress 5.0.2.0 software (Molecular Devices Inc.). Images of
actin localisation were projected from prophase to metaphase
(ImageJ, z-projection standard deviation) for analysis. For the analy-
sis of cortical membrane elongation, images were taken every
1 min, and movies were made in the MetaXpress 5.0.2.0 software
(Molecular Devices Inc.).
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Quantification of spindle orientation
U2OS cells were seeded at 3,000 cells per well in 96-well plates with
L-shaped micropatterns (CYTOO) at a density of 15,000 cells/ml.
Prior to seeding, plates were coated with 20 lg/ml fibronectin
(Sigma) for 2 h at RT. Following seeding, cells were imaged every 5
or 10 min for up to 24 h at 37°C in a 5% CO2 environmental cham-
ber using an ImageXpress Micro High Content Screening System
(Molecular Devices Inc.). To measure spindle orientation in subcon-
fluent cultures, cells were seeded at 50% confluency, grown over-
night and imaged as previously described [60]. Spindle angles were
measured using a vector drawn through the division axis at
anaphase bisecting a vector drawn through the cell’s long axis deter-
mined prior to prophase.
Flow cytometry
For cell cycle distribution profiles, U2OS cells treated with or with-
out synchronisation agents as described above were collected and
washed 2× in PBS + 1% (v/v) FBS. Cells were fixed in 90% (v/v)
ice-cold methanol for either 20 min or O/N at 20°C. Following fix-
ation, cells were washed 2× in PBS + 1% FBS and stained with DNA
staining buffer (50 lg/ml propidium iodide, 50 lg/ml RNase A, in
PBS + 1% FBS). Following 20-min incubation at RT protected from
light, samples were analysed and data acquired on a fluorescence-
activated cell sorting (FACS) Canto [Becton Dickinson, (BD)] using
BD FACSDIVA Software. Data were visualised using FlowJo soft-
ware (Tree Star, BD). Pulse-width analysis was used to ensure the
exclusion of doublets and clumps prior to evaluation of cell cycle
distribution using the Watson-Pragmatic model.
Generation of FAM83D/ knockout, FAM83DGFP/GFP,
FAM83DGFP/GFP(F283A), FAM83DcDNA-rescue cells,
mCherry/mCherryCSNK1A1 and mCherry/mCherryCSNK1E knockin cells
using CRISPR/Cas9
To generate FAM83D/ knockout by CRISPR/Cas9 genome editing,
U2OS cells were transfected with vectors encoding a pair of guide
RNAs (pBABED-Puro-sgRNA1 and pX335-CAS9-D10A-sgRNA2)
targeting around the first exon of FAM83D (1 lg each). For GFP
knockins, U2OS cells were transfected with vectors encoding a pair
of guide RNAs (pBABED-Puro-sgRNA1 and pX335-CAS9-D10A-
sgRNA2) targeting around the stop codon of FAM83D (FAM83DGFP/GFP)
or the region surrounding the codon encoding amino acid F283
(FAM83DGFP/GFP(F283A)), along with the respective donor plasmid
carrying the GFP knockin insert and flanking homology arms (~500
bases) (3 lg each). For the FAM83DGFP/GFP(F283A) knockin, the 50
homology arm of the GFP donor was extended to 1,000 bp, in order
to cover the desired site of mutation. For mCherry knockins,
FAM83DGFP/GFP cells were transfected with vectors encoding a pair
of guide RNAs (pBABED-Puro-sgRNA1 and pX335-CAS9-D10A-
sgRNA2, 1 lg each) targeting around the start codon of CSNK1A1 or
CSNK1E, along with the respective donor plasmid carrying the
mCherry knockin insert and flanking homology arms (~500 bases)
(3 lg each). To restore FAM83D in the knockout environment, we
transfected the FAM83D/ cells with a pair of guide RNAs
(pBABED-Puro-sgRNA1 and pX335-CAS9-D10A-sgRNA2) targeting
around the start codon of FAM83D, which had previously been
targeted for generation of FAM83D/ knockout cells, along with
the respective donor plasmid carrying the FAM83DcDNA-IRES-GFP-
polyA knockin insert with flanking homology arms (~500 bases)
(3 lg each). 16 h post-transfection, cells were selected in puromycin
(2 lg/ml) for 48 h. The transfection process was repeated one more
time. For the acquisition of single-cell clones of knockouts, and GFP
and mCherry knockins, single cells were isolated by fluorescence-
activated cell sorting (FACS) using an Influx cell sorter (Becton
Dickinson). Single cell clones were plated on individual wells of two
96-well plates, pre-coated with 1% (w/v) gelatin to help cell adher-
ence. Viable clones were expanded, and successful knockout or inte-
gration of GFP, mCherry or FAM83D cDNA at the target locus was
confirmed by both Western blotting and genomic DNA sequencing.
Generation of control and VHL-aGFP.16 AdPROM cell lines
Control and VHL-aGFP.16 AdPROM cell lines were generated as
described previously [22,23], using retroviral-based infections to
deliver the AdPROM constructs to the FAM83DGFP/GFP U2OS cells.
RNA interference
U2OS cells were transfected with either ON-TARGETplus Non-targeting
Control siRNAs (D-001810-01-05, Dharmacon) or ON-TARGETplus
SMARTpool-Human siRNA targeting CSNK1A1 (l-003957-00-0005,
Dharmacon) using Lipofectamine 3000 Reagent (L3000015, Thermo
Fisher). Lipid–siRNA mixtures were incubated with cells for 16 h,
and then, cells were washed. Cells were collected for analysis after a
further 48-h incubation post-transfection.
Cell lysis and immunoprecipitation
Cells were washed twice in ice-cold PBS, before scraping/harvesting
on ice in lysis buffer (50 mM Tris–HCl pH 7.5, 0.27 M sucrose,
150 mM NaCl, 1 mM EGTA, 1 mM EDTA, 1 mM sodium orthovana-
date, 10 mM sodium b-glycerophosphate, 50 mM sodium fluoride,
5 mM sodium pyrophosphate and 1% Nonidet P40 substitute),
supplemented with 1× cOmpleteTM protease inhibitor cocktail
(Roche). Cell extracts were either clarified and processed immedi-
ately, or snap frozen in liquid nitrogen and stored at 80°C. Protein
concentrations were determined in a 96-well format using the Brad-
ford protein assay reagent (Bio-Rad).
For Immunoprecipitations (IPs), clarified extracts were normal-
ised in lysis buffer to typically 1–5 mg/ml. After input aliquots were
collected, lysates were incubated for 4 h or O/N at 4°C with protein
G-sepharose beads coupled to the antibody of interest, on a rotating
wheel. For anti-FLAG IPs, FLAG M2 resin (Sigma) was used; for
anti-GFP IPs, GFP TRAP beads (ChromoTek) were used; and for
anti-mCherry IPs, RFP TRAP beads (ChromoTek) were used. For
anti-FAM83D IPs, anti-FAM83D-coupled sepharose beads were
used, and for anti-CK1a IPs, anti-CK1a-coupled sepharose beads
were used, using our in house generated anti-FAM83D and anti-
CK1a antibodies, respectively. Sheep IgG-coupled sepharose beads
were employed as a control for endogenous IPs. Following incuba-
tion, beads were pelleted and flow-through extracts collected. Beads
were washed once in lysis buffer supplemented with 250 mM NaCl,
and 2–3 times in lysis buffer. For elution, beads were resuspended
in 1× SDS sample buffer and incubated at 95°C for 5 min.
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For mass spectrometry, IPs were performed as described
above except that, prior to incubation with the relevant anti-
body-coupled beads, extracts were pre-cleared by incubating with
protein G-sepharose beads for 1 h at 4°C on a rotating wheel.
For elution, samples were boiled at 95°C for 5 min in 1× SDS
sample buffer and eluted by spinning through SpinX columns
(Corning).
SDS–PAGE and Western blotting
Reduced protein extracts (typically 10–20 lg protein) or IPs were
resolved on either 8 or 13% (v/v) SDS–PAGE gels, or 4–12%
NuPAGE bis-tris precast gradient gels (Invitrogen) by electrophore-
sis. Separated proteins were subsequently transferred onto
polyvinylidene fluoride (PVDF) membranes (Millipore), before
membranes were blocked in 5% (w/v) non-fat milk powder
(Marvel) in TBS-T (50 mM Tris–HCl pH 7.5, 150 mM NaCl, 0.2%
(v/v) Tween-20) and incubated overnight at 4°C in either 5% milk
TBS-T or 5% bovine serum albumin (BSA) TBS-T with the appropri-
ate primary antibody. Membranes were then washed for 3 × 10 min
with TBS-T before incubating with HRP-conjugated secondary anti-
bodies in 5% milk TBS-T for 1 h at RT. Membranes were then
washed for 3 × 10 min with TBS-T before detection with enhanced
chemiluminescence reagent (Millipore) and exposure to medical-
grade X-ray films (Konica Minolta), as described previously
[20,59,61]. Alternatively, membranes were imaged using the Chemi-
DocTM system (Bio-Rad).
Antibodies
The antibodies used in this study are listed in Table 1. The source,
catalogue number and dilution factor used for each antibody are
provided. Additionally, we provide references for the antibody
specificity tests and highlight which antibody was used in each fig-
ure. For non-commercially sourced antibodies, antibodies were
generated by the Division of Signal Transduction Therapy (DSTT),
University of Dundee as described previously [20,59]. For HRP-coupled
secondary antibodies, goat anti-rabbit-IgG (cat.: 7074, 1:2,500) was
from CST, and rabbit anti-sheep-IgG (cat.: 31480, 1:5,000), goat anti-
rat IgG (cat.: 62-9520, 1:5,000) and goat anti-mouse-IgG (cat.: 31430,
1:5,000) were from Thermo Fisher Scientific.
For immunofluorescence studies, signal amplification was
achieved using AlexaFluor-594-conjugated donkey anti-sheep IgG
(H+L) (cat.: A11058, Life Technologies, 1:300), AlexaFluor-594-
conjugated goat anti-rabbit IgG (H+L) (cat.: A11012, Life Technologies,
1:500) and goat anti-mouse IgG (H+L) (cat.: A11005, Life Technologies,
1:500).
Fluorescence microscopy
Cells were seeded onto glass coverslips and treated/transfected as
described above or in figure legends. Cells were washed 2× in PBS,
before fixing in 4% (w/v) paraformaldehyde (PFA) for 20 min at
RT. Cells were washed 2× in DMEM/10 mM HEPES, followed by
incubation in DMEM/10 mM HEPES for 10 min. Cells were washed
once in PBS and permeabilised for 3 min in 0.2% NP-40. Following
permeabilisation, cells were washed 2× in PBS containing 1% (w/v)
BSA, followed by incubation in PBS/BSA for 15 min. Where
appropriate, coverslips were then incubated with primary antibody
in PBS/BSA (typically at 1:100-1:500 dilution) at 37°C for 1–1.5 h.
Cells were washed for a minimum of 3 × 10 min in PBS/BSA before
incubation with the secondary AlexaFluor-conjugated antibody in
PBS/BSA (1:300–500 dilution) for 60 min at RT protected from light.
Coverslips were subsequently washed for 3 × 10 min in PBS/BSA
and mounted on glass microscopy slides using ProLong Gold anti-
fade reagent with DAPI (Life Technologies). Coverslips were sealed
with clear nail varnish and left to dry overnight before analysis on a
Zeiss LSM710 confocal microscope using a 63× Plan-Apochromat
objective (NA 1.40). Alternatively, cells were imaged on a Nikon
TiE inverted microscope (60× objective) and visualised with NIS
Elements (Nikon). Images were processed with Omero [62].
For quantification of CK1a spindle localisation, the mean pixel
intensities of CK1a staining on the spindle were calculated by
measuring the mean pixel intensities of CK1a in the region of inter-
est (roi) demarcated by the outer border of the DAPI ring (hereafter
referred to as the spindle roi). Subsequently, the ratio between the
spindle roi and the background cytoplasmic CK1a staining was
calculated, by measuring the mean cytoplasmic CK1a pixel intensi-
ties in the cytoplasmic roi, defined as the whole cell minus the
spindle roi. The resulting ratios were plotted on a box plot with
whiskers indicating the highest and lowest values. A ratio of > 1
indicates CK1a is present on the spindle, and a ratio of ≤ 1 indicates
CK1a is not present on the spindle. One might expect the theoretical
ratio to be close to 1 in the FAM83D/ cells. However, lower mean
CK1a intensity in the DAPI-stained area relative to the cytoplasm
implies exclusion of CK1a in DNA-rich regions. This results in a
lower mean CK1a staining intensity in the overall spindle roi versus
the cytoplasmic roi and therefore a ratio of < 1. The ImageJ macro
developed by Graeme Ball (Dundee Imaging Facility), used for this
purpose, is included as a supplementary file (Appendix File S1).
Mass spectrometry
Proteins were affinity purified from clarified extracts by GFP TRAP
beads (ChromoTek) as described above. Purified proteins were
resolved on 4–12% gradient gels by SDS–PAGE, and gels were
subsequently stained with InstantBlueTM (Expedeon). Gel slices
covering each lane were excised and digested with trypsin. The tryp-
tic peptides were subjected to mass spectrometric analysis
performed by LC-MS-MS on a Linear ion trap-orbitrap hybrid mass
spectrometer (Orbitrap-VelosPro, Thermo) coupled to a U3000 RSLC
HPLC (Thermo). Peptides were trapped on a nanoViper Trap
column, 2 cm × 100 lm C18 5 lm 100 A˚ (Thermo, 164564), then
separated on a 15 cm Thermo EasySpray column (ES800) equili-
brated with a flow of 300 nl/min of 3% Solvent B [Solvent A: 2%
Acetonitrile, 0.1% formic acid, 3% DMSO in H2O; Solvent B: 80%
acetonitrile, 0.08% formic acid, 3% DMSO in H2O]. The elution
gradient was as follows: Time(min):Solvent B(%); 0:3, 5:3, 45:35,
47:99, 52:99, 55:3, 60:3. Data were acquired in the data-dependent
mode, automatically switching between MS and MS-MS acquisition.
Full scan spectra (m/z 400–1,600) were acquired in the orbitrap
with resolution R = 60,000 at m/z 400 (after accumulation to an
FTMS Full AGC Target; 1,000,000; FTMS MSn AGC Target; 50,000).
The 20 most intense ions, above a specified minimum signal thresh-
old (2,000), based upon a low resolution (R = 15,000) preview of
the survey scan, were fragmented by collision induced dissociation
ª 2019 The Authors EMBO reports e47495 | 2019 15 of 19
Luke J Fulcher et al EMBO reports
and recorded in the linear ion trap (Full AGC Target; 30,000. MSn
AGC Target; 5,000). Data files were analysed by Proteome Discov-
erer 2.0 (www.ThermoScientific.com), using Mascot 2.4.1
(www.matrixscience.com), and searching the SwissProt Human
database. Scaffold Q/Q+S V4.4.7 (www.ProteomeSoftware.com)
was also used to examine the Mascot result files. Allowance was
made for the following fixed, carbamidomethyl (C) and variable
modifications, oxidation (M), and dioxidation (M). Error tolerances
were 10 ppm for MS1 and 0.6 Da for MS2. Scaffold Q/Q+S V4.4.6
(www.ProteomeSoftware.com) was used to further analyse the data
and obtain values for the total unique peptide counts for each
protein.
For the qualitative analysis of FAM83D-interacting proteins, we
employed a strict set of requirements when determining whether a
protein was likely to interact with FAM83D in asynchronous (AS),
mitotic (M) or both AS and M conditions. For both nocodazole and
STLC treatments, only proteins, which were identified by at least
five total unique peptides, were included in the analysis. Crucially,
there must have been > 5 total unique peptides between the nega-
tive control and AS or M samples for a protein to be considered as a
non-contaminant. To be deemed as an AS- or M-specific FAM83D-
interacting protein, there must have been greater than 10 total
unique peptides between the AS and M samples.
RNA-isolation, cDNA synthesis and qRT–PCR
Cells were washed in PBS, and RNA was isolated following the
manufacture’s guidelines (Qiagen). cDNA synthesis and qRT–PCR
were performed as described previously [14,22]. The following
primer pairs were used: FAM83D (Forward: ACGTTGATTGATGG
CATCCG; Reverse: CCTTGGACTGTGGTTTTCGG), HMMR (Forward:
CAAAAGAGAAACAAAGATGAG-GGG; Reverse: CCACTTGATCTGA
AGCACAAC), CK1a (Forward: AATGTTAAAG-CAGAAAGCAGCAC;
Reverse: TCCTCAATTCATGCTTAGAAACC), cyclin B1 (Forward:
Table 1. Antibodies used in this study.
Antigen Source Cat. Number Dilution Used in Figure Specificity Ref.
CK1a Bethyl A301-991A WB: 1:1,000 1D E, G, H and I, and 2D and 4B–D and 5F
and EV3A and B, Appendix Fig S1A
12
CK1a DSTT (University of
Dundee)
Sheep SA527,
third bleed
WB: 1:1,000;
IF: 1:1,000
3B and F, and 4G and I, and 5B and C,
and EV4A–C
This study
CK1a Santa Cruz sc-6477 IF: 1:100 2A, B and G, and 3D and 5D and EV3C 12
CK1e CST 12448 WB: 1:1,000 1D and EV5B 12
CK1e DSTT (University of
Dundee)
Sheep SA610,
second bleed
WB: 1:1,000 EV4A–C This study
CK1e Sigma-Aldrich HPA026288 IF: 1:500 EV2A 12
CK1d CST 12417 WB: 1:1,000 1D 12
Cyclin A2 CST 4656 WB: 1:1,000 1I This study
Cyclin B1 CST 4138 WB: 1:1,000 1D, E and I, and 4A–D This study
DYNLL1 Abcam EP1660Y WB: 1:1,000 1D This study
FAM83D
(C-term)
DSTT (University
of Dundee)
Sheep SA102,
third bleed
WB: 1:1,000;
IF: 1:500
1A, D, E, H and I, and 2D and F, and 3B, C
and F and 4A–D and 5B, C and F, and EV3A
and B, and EV4B and EV5B
This study
FAM83D
(N-term)
DSTT (University
of Dundee)
Sheep SA102,
third bleed
WB: 1:1,000 1A and G, and 4G This study
FAM83G DSTT (University
of Dundee)
Sheep S876C,
third bleed
WB: 1:1,000 EV4C 12,14
GAPDH CST 14C10 WB: 1:5,000 1A, D, E, G, H and I, and 2D and F, and 4A–D
and G, and 5B, C and F, and EV3A and
B, and EV4A
GAPDH Proteintech 10494-01-AP WB: 1:5,000 Appendix Fig S1A
GFP Roche 11814460001 WB: 1:500 3B This study
HMMR Millipore ABC323 WB: 1:1,000;
IF: 1:500
1D, E and I, and 2D and 4B–D and EV2B
and EV3A and B
This study
HMMR Abcam 124729 WB: 1:1,000;
IF: 1:500
4G and H This study
p-Histone
H3 (S10)
CST 9701 WB: 1:1,000 4B This study
VHL CST 68547 WB: 1:1,000 2F 22,23
CST, cell signaling technology; DSTT, division of signal transduction therapy; WB, Western blotting; IF, immunofluorescence.
All the antibodies used in this study are listed, along with their source, catalogue number and dilution factor used. References for antibody specificity and details
of the figures in which each antibody was used are also provided.
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GCAGTGC-GGGGTTTAAATCT; Reverse: GCCATGTTGATCTTCGCCTT)
and GAPDH (Forward: TGCACCACCAACTGCTTAGC; Reverse: GGC
ATGGACTGTGGTCATGAG). Primers were obtained from Invitrogen.
Phosphatase assays
Lysed extracts were subjected to GFP TRAP immunoprecipitation
and washed 3× in wash buffer (200 mM NaCl, 50 mM Tris–HCl pH
7.5, 1% Triton X-100). Beads were resuspended in 20 ll phos-
phatase-assay buffer [New England Biolabs (cat.: PO753)] contain-
ing 1 mM MnCl2, with or without k-phosphatase (1 U) for 30 min at
30°C, with shaking. Following incubation, beads were washed 3× in
wash buffer and eluted. Input and immunoprecipitation samples
were subjected to Western blotting as described above.
Purification of recombinant proteins
Most recombinant proteins used in the in vitro kinase assays were
purified by the Division of Signal Transduction Therapy (DSTT;
University of Dundee), and the identities of the expressed proteins
verified by mass spectrometry. Each protein has a unique identifi-
cation number to request from the MRC-PPU Reagents website
(http://mrcppureagents.dundee.ac.uk) as follows: GST-CK1a (DU329)
and GST-FAM83D (DU28270). GST-FAM83G-6xHis was purified by
Polyxeni Bozatzi [14]. Briefly, the proteins were expressed in BL21
(DE3) E. coli as described previously [12], and affinity purified
using GSH-sepharose or Nickel-agarose columns as appropriate.
Kinase assays
For peptide-based kinase assays, reactions were set up and
performed as described by Hastie et al [63] except that FAM83D-
GFP IPs, in which endogenous CK1a co-immunoprecipitated, or
mCherry-CK1a/e IPs, were used instead of recombinant proteins.
An optimised CK1 peptide [CK1tide (KRRRALS*VASLPGL), where
S* indicates phospho-Ser] was used as the substrate. Assays were
performed using samples from three biological replicates.
For recombinant substrate-based kinase assays, 25-ll reactions
containing 200 ng of kinase (GST-CK1a) and 2 lg of substrate (Pre-
cision protease-cleaved FAM83D, initially expressed as GST-
FAM83D) in a buffer composed of 50 mM Tris–HCl (pH 7.5),
0.1 mM EGTA, 10 mM magnesium acetate, 2 mM DTT and 0.1 mM
[c32P]-ATP (500 cpm/pmol). Following 30-min incubation at 30°C,
assays were stopped by adding 9 ll of 4× SDS sample buffer
containing 5% (v/v) b-mercaptoethanol, with subsequent heating at
95°C for 5 min. Samples were resolved by SDS–PAGE, and the gels
were stained with InstantBlue (Expedeon) and dried. Radioactivity
was analysed by autoradiography.
Statistical analysis
For qRT–PCR data, GraphPad (Prism) was used to generate plots
and analyse data by unpaired Student’s t-test. A P-value of < 0.05
was deemed significant. For quantification of CK1a spindle localisa-
tion, kinase assays and spindle orientation studies, GraphPad
(Prism) was used to generate plots and analyse data by one-way
ANOVA, followed by a post hoc Tukey’s test. A P-value of < 0.05
was deemed significant.
Data availability
The mass spectrometry proteomics data have been deposited to the
ProteomeXchange Consortium via the PRIDE partner repository with
the dataset identifier PXD013808 (https://www.ebi.ac.uk/pride/arc
hive/projects/PXD013808).
Expanded View for this article is available online.
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